Medicskin Holdings Limited
Hong Kong Stock ExchangeTotal Valuation
Medicskin Holdings Limited carries a market capitalization of 44.83M, placing it among publicly traded companies globally. Its enterprise value stands at 84.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 44.83M |
| Enterprise Value | 84.24M |
Share Statistics
Medicskin Holdings Limited currently has 396.74M shares outstanding.
| Shares Outstanding | 396.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1.65, and the price-to-book ratio stands at 31.28.
| PE Ratio | N/A |
| PS Ratio | 1.65 |
| PB Ratio | 31.28 |
| P/TBV Ratio | 9.13 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Medicskin Holdings Limited trades at an EV/EBITDA multiple of 13.88 and an EV/FCF ratio of 128.75. The EV/Sales ratio of 1.68 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.88 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.68 |
| EV / EBITDA | 13.88 |
| EV / EBIT | 13.88 |
| EV / FCF | 128.75 |
Financial Position
Medicskin Holdings Limited maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 104.11, indicating elevated leverage, while an interest coverage ratio of 9.26 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.87 |
| Quick Ratio | 0.15 |
| Debt / Equity | 104.11 |
| Debt / EBITDA | 1.55 |
| Interest Coverage | 9.26 |
Financial Efficiency
| Return on Equity (ROE) | -54.32 |
| Return on Assets (ROA) | -4.04 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.80 |
Taxes
Over the trailing twelve months, Medicskin Holdings Limited has paid -2,000.00 in income taxes, reflecting an effective tax rate of 0.61.
| Income Tax | -2,000.00 |
| Effective Tax Rate | 0.61 |
Stock Price Statistics
Medicskin Holdings Limited's stock has declined approximately -18.70504% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.70504% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.15 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medicskin Holdings Limited generated 50.08M in revenue and converted that into -1.79M in net income, yielding earnings per share of 0.00. EBITDA reached 6.07M, while operating income came in at 6.07M.
| Revenue | 50.08M |
| Gross Profit | 40.05M |
| Operating Income | 6.07M |
| Pretax Income | -1.84M |
| Net Income | -1.79M |
| EBITDA | 6.07M |
| EBIT | 6.07M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Medicskin Holdings Limited holds 4.35M in cash and equivalents against 9.41M in total debt, resulting in a net debt position of -3.35M. Total book value stands at 2.64M, with working capital of -3.77M providing operational flexibility.
| Cash & Cash Equivalents | 4.35M |
| Total Debt | 9.41M |
| Net Debt | -3.35M |
| Equity (Book Value) | 2.64M |
| Book Value Per Share | 0.01 |
| Working Capital | -3.77M |
Margins
Medicskin Holdings Limited operates with a gross margin of 79.98, reflecting its pricing power and cost economics. The operating margin of 12.12 and net profit margin of -3.58 provide insight into operational efficiency.
| Gross Margin | 79.98 |
| Operating Margin | 12.12 |
| Pretax Margin | -3.68 |
| Profit Margin | -3.58 |
| EBITDA Margin | 12.12 |
Scores
Medicskin Holdings Limited posts an Altman Z-Score of 3.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.15 |